Progress on diabetic endothelial progenitor cell

Endothelial progenitor cell(EPC) is bone marrow-derived stem cells with the capacity to restore endothelium and promote postnatal angiogenesis.The decreased number and function of EPCs in patients with diabetes mellitus may be a promising target for treatment.This review describes the role of EPC on diabetes pathology,as well as its related drug therapy.